Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBOLA Z CHAD3-004 pediatric Ebola vaccine study
PACTR201507001154522Not yet recruiting
- Sponsor
- GSK
- Start
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 5
01
Overview
Randomised trial of Meningococcal polysaccharide vaccine group W-135 and cAd3-EBOV in Ebola virus disease (EVD) (2 arms), sponsored by GSK. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
Meningococcal polysaccharide vaccine group W-135cAd3-EBOV
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201507001154522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201507001154522.